课题基金 / 基金详情

Requirements for regulatory T cell development

Requirements for regulatory T cell development
调节性 T 细胞发育的要求
批准号:
6352348
负责人:
MICHELE M KOSIEWICZ
金额:
$21.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-15 至 2004-08-31

项目摘要

项目成果

MICHELE M KOSIEWICZ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Natural regulatory T cells (CD25+, CD45RBlo) appear to be responsible for controlling autoreactive T cell activity and, thereby, the development of autoimmune diseases. They are present in naive mice and express an activation/memory surface marker phenotype. These cells do not proliferate in response to a variety of stimuli, but are very potent inhibitors of effector T cell proliferation in vitro. Although some progress has been made in understanding their mechanisms of action, little is known about their requirements for development or peripheral activation. Evidence suggests that natural regulatory T cells may undergo selection/activation at both the thymus and peripheral sites, such as the mucosa. The gut, in particular, is a strong candidate for this mucosal site since exposure to antigen through these tissues tends to result in tolerance rather than immunity, and the antigenic load is huge and extremely diverse. We propose that natural regulatory T cell development requires two stages of activation to become fully functional; an induction and an effector stage, both of which may involve the gut mucosa. Using in vitro and in vivo assays, our studies will address three specific aims: (1) to characterize the basic requirements for development of natural regulatory T cells; (2) to determine whether GALT is involved in the induction stage of natural regulatory T cell development; and (3) to determine whether GALT is critical for the secondary activation of natural regulatory T cells in the periphery. These experiments may determine the requirements for regulatory T cell development, and thereby, identify pathways that can be therapeutically manipulated to prevent and/or treat autoimmune diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interplay of androgens, microbiota and immunoregulation in lupus
  • 批准号:
    8969464
  • 项目类别:
  • 资助金额:
    $41.26万
  • 财政年份:
    2015
  • 负责人:
    MICHELE M KOSIEWICZ
  • 依托单位:
Interplay of androgens, microbiota and immunoregulation in lupus
  • 批准号:
    9766076
  • 项目类别:
  • 资助金额:
    $40.61万
  • 财政年份:
    2015
  • 负责人:
    MICHELE M KOSIEWICZ
  • 依托单位:
Interplay of androgens, microbiota and immunoregulation in lupus
  • 批准号:
    9068816
  • 项目类别:
  • 资助金额:
    $43.79万
  • 财政年份:
    2015
  • 负责人:
    MICHELE M KOSIEWICZ
  • 依托单位:
Interplay of androgens, microbiota and immunoregulation in lupus
  • 批准号:
    9330062
  • 项目类别:
  • 资助金额:
    $43.19万
  • 财政年份:
    2015
  • 负责人:
    MICHELE M KOSIEWICZ
  • 依托单位:
海外基金